Methods and compositions for treatment of pulmonary hypertension and other lung disorders
US12263174B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2022 |
| Grant date | Apr 1, 2025 |
| Priority date | — |
| Expiry date | Sep 11, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating pulmonary hypertension. The methods include administering to a subject in need thereof an effective amount of a vasodilator, wherein the vasodilator is administered to the subject via inhalation pro re nata using a portable inhaler. In some embodiments, the vasodilator is a PDE5 inhibitor. Pharmaceutical compositions for pro re nata administration of vasodilators are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.